Dr. Kahn is Chairman and a tenured professor of the Department of Oral and Maxillofacial Pathology at Tufts University School of Dental Medicine. He also serves as the Director of the department’s Divisions of Educaton and Professional Services and Laboratory Director of Tufts Oral Pathology Services. He completed his residency training in oral and maxillofacial pathology at Emory University School of Dentistry after having served as a general dentist both in the U.S. Army and in private practice.He then completed a post-doctoral fellowship in pathology at Temple University’s School of Dental Medicine. Dr. Kahn accepted a position at the University of Tennessee College of Dentistry where he spent 14 years, during which he was promoted to full professor with tenure, served as director of the oral and maxillofacial pathology services and received the Health Science Center’s Excellence in Teaching Award on three occasions.He has authored more than 50 articles in professional journals and a dental therapeutics books and has given more than 350 presentations and continuing education courses locally, regionally and nationally. He is a fellow of the International College of Dentists, American College of Dentists, Pierre Fauchard Academy and American Academy of Oral and Maxillofacial Pathology. Dr. Kahn is a Diplomate of the American Board of Oral and Maxillofacial Pathology.
Contact Dr. Kahn at (617) 636-6510 or firstname.lastname@example.org.
Dr. Mike Hall is an assistant professor in the Department of Oral and Maxillofacial Pathology at Tufts University School of Dental Medicine.? Dr. Hall graduated from the University of Oklahoma College of Dentistry in 1980 and after completing a general practice residency at the VA Medical Center in Oklahoma City, he practiced general dentistry for four years.? Dr. Hall then earned a three-year oral and maxillofacial pathology certificate at Emory University School of Dentistry (Atlanta, GA) in 1987 whereupon he held academic positions at the University of Saskatchewan, Canada; Medical College of Georgia (Augusta); and the Mayo Clinic in Rochester, MN.
Dr. Hall has published in the medical and dental peer-reviewed literature on a variety of pathology subjects and remains active in research with a special interest in bone tumors of the jaws.? He has also given numerous invited lectures and presentations at conferences.? Dr. Hall recently earned a Masters degree in Bioethics and Medical Humanities from the University of South Florida?s College of Medicine, Department of Internal Medicine.
Contact Dr. Hall at 617-636-6545 or James.Hall@tufts.edu.
Nora M. Laver, M.D.
Associate Clinical Professor, Oral and Maxillofacial Pathology
Dr. Laver is a graduate of the University of Buenos Aires School of Medicine, Buenos Aires, Argentina. She completed a residency in pathology at Georgetown University Medical Center, Washington, DC. She then completed a fellowship
in cytopathology at Georgetown University Medical Center, and Callender-Binford Fellowships in ocular pathology and in oral and maxillofacial pathology, both at the Armed Forces Institute of Pathology, Washington D.C. Dr. Laver is Associate Professor of Ophthalmology and Associate Professor of Pathology at Tufts University School of Medicine and School of Dentistry. In addition to directing ocular pathology at the New England Eye Center, she has served as Director of Pathology Residency Training, Director of Cytopathology and Director of Head and Neck Pathology. She is a consultant to the Boston University Department of Pathology. Dr. Laver has published over 45 medical peer-reviewed articles, 9 book chapters, has organized two head and neck cancer conferences, participated in numerous presentations and continuing education courses locally, regionally and internationally.
Dr. Laver’s training and experience uniquely qualify her to evaluate head and neck pathology specimens. She is certified by the American Board of Pathology in anatomic pathology and cytopathology. She is available for consultation regarding the entire spectrum of head and neck pathology cases, including fine needle aspirations specimens, biopsies and resection specimen. Methods include standard histology, immunofluorescence studies, immunohistochemistry, in situ hybridization, flow cytometry, PCR, and electron microscopy studies.
Additional Research Faculty
Jonathan Garlick, DDS, PhD
Dr. Jonathan Garlick is Professor in the Department of Oral and Maxillofacial Pathology and Director of the Division of Cancer Biology and Tissue Engineering at Tufts University School of Dental Medicine. Dr. Garlick also holds appointments at Tufts University’s School of Medicine (Department of Anatomy and Cell Biology) and in the Department of Bioengineering and is a member of the Program in Cell, Molecular and Developmental Biology at Tufts.
He is a graduate of Stony Brook University’s School of Dental Medicine where he received his dental degree. He completed his residency training in Oral and Maxillofacial Pathology at Long Island Jewish Medical Center and received his Ph.D. from Stony Brook University through a Physicians-Scientist Award from the NIH.
Dr. Garlick remained at Stony Brook for 10 years, where he was Head of Oral Pathology and Oral Medicine. His expertise in the bioengineering of human skin equivalents has led him to establish the Center for Integrated Tissue Engineering (CITE) at Tufts as a resource for experimentation in three-dimensional (3D) human tissues. He has developed techniques for the bioengineering of human epithelial tissues to study the pathogenesis of a variety of oral and skin diseases. Dr. Garlick has used these tissues to study early cancer development and to add to the emerging understanding of cancer as a disease of altered tissue structure. These 3D bioengineered human tissues now serve as a platform technology for the pharmaceutical design and screening of drugs targeted for specific therapeutic applications to treat human cancer.
He has authored over 60 articles and book chapters on these subjects. On the national level, Dr. Garlick has served as Chair and as a member of several NIH grant review panels, is on the editorial board of several scientific journals and has chaired numerous national symposia. In 2000, he was awarded Stony Brook School of Dental Medicine’s Distinguished Alumnus Award in recognition of his local and national contributions to the dental profession. In 2001, he was awarded the President and Chancellor’s Award, the State University of New York’s highest teaching honor for his educational contributions in Oral Pathology and Oral Medicine to the students of Stony Brook University’s Dental School.
Contact Dr. Garlick at (617) 636-2444 or Jonathan.Garlick@tufts.edu.
William M. Morlang, DDS
William M. Morlang, D.D.S. is a forensic odontologist and disaster management consultant in San Antonio, Texas. He serves as a forensic consultant to the Armed Forces Medical Examiner, Armed Forces Institute of Pathology, and Air Force Office of Special Investigation. He is an adjunct Associate Professor, School of Dental Medicine, Tufts University. He is also a faculty member at the Armed Forces Institute of Pathology.
Dr. Morlang is a graduate of the University of Florida, West Virginia University, Armed Forces Staff College, National Defense University, and Inter-Agency Institute for Federal Healthcare Executives at George Washington University. He trained in oral pathology, forensic dentistry, aerospace pathology, and advanced forensic pathology at the Armed Forces Institute of Pathology and FBI Academy. He served in the U.S. Air Force from 1966 until 1996, earning the rank of colonel in 1979. He is a diplomate of the American Board of Forensic Odontology (ABFO) and served on the ABFO Board of Directors, ABFO Research Committee, ABFO Mass Disaster Committee, ABFO Bitemark Committee, and ABFO Certification and Examining Committee.
Dr. Morlang was the 1996 president of the American Society of Forensic Odontology (ASFO) and served on the ASFO Board of Governors. He is a fellow of the American Academy of Forensic Sciences, Academy of General Dentistry, American College of Dentists, and International College of Dentist. He is a member of the American College of Legal Medicine, American Academy of Oral and Maxillofacial Radiology, and American Dental Association.
His extensive experience in mass disaster management and identification of human remains includes: Big Thompson Canyon Flood, Pan Am/KLM 747 mishap, Jonestown Guyana tragedy, two LOT Polish Airline accidents, Arrow Airways mishap, Grenada assassinations, Battleship Iowa explosion, numerous military aircraft accidents and Vietnam war. Col. Morlang served as the Consultant in Forensic Dentistry to the USAF Surgeon General and was the first military officer to introduce bitemark evidence into federal court. Dr. Morlang is a recognized Total Quality Management leader and educator, and an experienced Malcolm Baldridge Quality Award evaluator. He has lectured internationally on forensic sciences, mass disaster management, and quality leadership. Dr. Morlang has written numerous forensic articles, syllabi, mass disaster management plans, and textbook chapters.
Contact Dr. Morlang at (210) 651-5848, or by email at email@example.com.
Naomi Rosenberg, PhD
In February 2004, Dr. Naomi Rosenberg was appointed the Dean of the Sackler School of Graduate Biomedical Sciences. She is also a Professor of Pathology at Tufts University School of Medicine and holds an academic appointment in the Department of Oral and Maxillofacial Pathology at Tufts University School of Dental Medicine. Dr. Rosenberg earned her A.B. Biology degree at Boston University and her Ph.D. from the University of Vermont. She completed postdoctoral training at the Massachusetts Institute of Technology in the mid-1970s and joined Tufts University at the Boston campus’ cancer research center in 1977 upon completion of that program. She was among Sackler’s first faculty when the school was created as part of the medical school in 1983. She helped develop and for years directed the school’s genetics program.
In her role as Dean, Dr. Rosenberg is responsible for the Ph.D. and related education training programs of the Sackler School. She also plays a key role working with the medical school Dean Michael Rosenblatt in strategic planning for research on the Health Sciences campus.
Currently, Dr. Rosenberg conducts research in the Department of Pathology investigating the ways cancer develops. She has achieved a distinguished record of achievement in her laboratory. For example, she developed the first tractable model to study leukemia development in vitro using Abelson murine leukemia virus, work that paved the way for identification of the abl oncogene and the discovery that this oncogene is responsible for human chronic myelogenous leukemia (CML). These discoveries were central to the development of imantinib, a drug used to treat CML. This model system also played a major role in experiments that led to understanding the basic process whereby genes are rearranged so that antibody molecules can be produced, a critical step in the immune response. Her lab continues to use a genetic approach to dissect the ways in which the Abl oncoprotein alters cell growth and has found that one important aspect of the process is blocking the natural death response of cells.
At the national level, Dr. Rosenberg has served on numerous federal committees and is presently a member of the Recombinant DNA Advisory Committee of the National Institutes of Health (NIH) and a member of the Board of Directors of the Leukemia and Lymphoma Society of America. Previously, she has served on the Board of Scientific Counselors of the National Cancer Institute of the NIH. Dr. Rosenberg has mentored 25 successful Ph.D. students and five others are currently training in her laboratory. She has been funded by the NIH continuously for 27 years.
Contant Dr. Rosenberg at (617) 636-2143 or firstname.lastname@example.org.
Christophe Egles, Ph.D.
Dr. Christophe Egles joined Tufts University in the Division of Cancer Biology and Tissue Engineering as an Assistant Professor in July 2005 and serves as the Associate Director of the Center for Integrated Tissue Engineering (CITE). Dr. Egles earned his B.S. in Biochemistry and his Ph.D. in Neurobiology at the University Louis Pasteur in Strasbourg, France. From 1998 to 2001, he was a postdoctoral fellow at the Massachusettes Institute of Technology and, later, at Tufts University School of Medicine studied the molecular and cellular mechanisms underlying synapse formation during early steps of neural development. From 2001 to 2004, he served as Associate Professor at the University Louis Pasteur, School of Dentistry, where he studied the biomedical applications of biomaterials modifying cell/support interface, particularly for regenerative neurobiology or antibacterial protection. At the Division of Cancer Biology and Tissue Engineering his research is focused on biofunctionalized artificial matrices, developing wound healing models and creating anti-microbial surfaces for the protection of medical devices.
Contact Dr. Egles at (617) 636-3405 or by email: email@example.com.
Pamela Yelick, Ph.D.
Pamela Crotty Yelick, Ph.D., is a Professor, at Tufts University, Boston MA, where she is the Director of the Division of Craniofacial and Molecular Genetics in the Department of Oral and Maxillofacial Pathology. Dr. Yelick holds adjunct appointments in the Departments of Bioengineering, Genetics, and Molecular and Cell Biology. Dr. Yelick received her B.A. in Biology from Smith College, Northampton MA in 1979, and her Ph.D. in Molecular Biology from Tufts University in 1989. She received her postdoctoral training at the Dana Farber Cancer Institute, Boston MA and the Harvard Biological Laboratories, Cambridge MA. Dr. Yelick’s major research interests are molecular genetic analyses of craniofacial cartilage, bone, and tooth development. Her research focuses on manipulating mammalian postnatal dental stem cells for whole tooth tissue engineering applications, and the zebrafish, Danio rerio, as a model for craniofacial development and tooth regeneration. She has received grant support from multiple funding agencies including RO3, R21, R41 and RO1 support from NIH/NIDCR, and Proof of Principle, and Application Development Awards from the Center for Innovative Medicine and Innovative Technologies (CIMIT).
Contact Dr. Yelick at (617)-636-2430 or by email at firstname.lastname@example.org.